ECSP003783A - 2- (3,5-bis-trifluoromethyl-phenyl) -N-methyl-N- (6-morpholin-4-yl-4-o-totyl-pyridin-3-yl) -isobutyramide - Google Patents

2- (3,5-bis-trifluoromethyl-phenyl) -N-methyl-N- (6-morpholin-4-yl-4-o-totyl-pyridin-3-yl) -isobutyramide

Info

Publication number
ECSP003783A
ECSP003783A ECSP003783A ECSP003783A EC SP003783 A ECSP003783 A EC SP003783A EC SP003783 A ECSP003783 A EC SP003783A EC SP003783 A ECSP003783 A EC SP003783A
Authority
EC
Ecuador
Prior art keywords
isobutyramide
morpholin
pyridin
trifluoromethyl
bis
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Sonia Maria Poli
Andrew Sleight
Torsten Hoffmann
Theresa Maria Ballard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003783 priority Critical patent/ECSP003783A/en
Publication of ECSP003783A publication Critical patent/ECSP003783A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Este invento se refiere al compuesto de la fórmula que es la 2-(3,5-bis-trifluorometil-fenil)¿N-metil-N-(6-morfolin-4-il-4-o-tolil-piridin-3-il)-isobutiramida . Se ha encontrado que este compuesto tiene una alta afinidad al receptor NK-1 y es por tanto útil en el tratamiento de enfermedades relacionadas con este receptor.This invention relates to the compound of the formula which is 2- (3,5-bis-trifluoromethyl-phenyl) N-methyl-N- (6-morpholin-4-yl-4-o-tolyl-pyridin-3 -il) -isobutyramide. It has been found that this compound has a high affinity to the NK-1 receptor and is therefore useful in the treatment of diseases related to this receptor.

ECSP003783 2000-11-23 2000-11-23 2- (3,5-bis-trifluoromethyl-phenyl) -N-methyl-N- (6-morpholin-4-yl-4-o-totyl-pyridin-3-yl) -isobutyramide ECSP003783A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003783 ECSP003783A (en) 2000-11-23 2000-11-23 2- (3,5-bis-trifluoromethyl-phenyl) -N-methyl-N- (6-morpholin-4-yl-4-o-totyl-pyridin-3-yl) -isobutyramide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003783 ECSP003783A (en) 2000-11-23 2000-11-23 2- (3,5-bis-trifluoromethyl-phenyl) -N-methyl-N- (6-morpholin-4-yl-4-o-totyl-pyridin-3-yl) -isobutyramide

Publications (1)

Publication Number Publication Date
ECSP003783A true ECSP003783A (en) 2001-06-22

Family

ID=42041348

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003783 ECSP003783A (en) 2000-11-23 2000-11-23 2- (3,5-bis-trifluoromethyl-phenyl) -N-methyl-N- (6-morpholin-4-yl-4-o-totyl-pyridin-3-yl) -isobutyramide

Country Status (1)

Country Link
EC (1) ECSP003783A (en)

Similar Documents

Publication Publication Date Title
UY26458A1 (en) 2- (3,5-BIS-TRIFLUOROMETIL-FENIL) -N - METHYL - N - (6-MORFOLIN - 4 - YL -4- O- TOLIL - PIRIDIN -3 - YL) ISOBUTIRAMIDA
FR22C1036I1 (en) PYRIMIDINE DERIVATIVES AS HIV INHIBITOR
BR0113184A (en) Artificial implant and process to produce the same
CR7332A (en) INHIBITORS OF THE FACTOR Xa AND OTHER SERINE PROTEASES INVOLVED IN THE CASCADA DE LA COAGULACION
DE50203788D1 (en) PHARMACEUTICAL COMPOSITION FOR OPHTHALMOLOGICAL AND RHINOLOGICAL APPLICATION
ECSP024403A (en) SULFONIL-PIRROLIDINE DERIVATIVES USED FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
ATE464299T1 (en) NEW PHENYLALANINE DERIVATIVE
BR9910583A (en) Non-substituted aminotetralins as binders for the neuropeptide receptor y5 useful in the treatment of obesity and other disorders
DE60009511D1 (en) NEMATICIDAL TRIFLUORBUTENE
CY2008008I1 (en) N-Substituted Hydroxypyrimidinone Carboxamide Inhibitors of HIV Integration
EE200300440A (en) Combination of epothilone analogues and chemotherapeutic agents for the treatment of proliferative diseases
CY1108725T1 (en) Combination of NMDA antagonist and acetylcholinesterase inhibitors for the treatment of ALZHEIMER
ME00901B (en) Mesylate trihydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chlor0-1,3-dihydro-2h-indol-2-0ne
BR0208142A (en) Combinations comprising an antidiarrheal agent and epothilone or epothilone derivative
PA8567001A1 (en) ZIPRASIDONE COMPOSITION AND SYNTHETIC CONTROLS
ES2421948T3 (en) Compounds and compositions for delivering active agents
NO20033584L (en) Wide-spectrum 2- (substituted-amino) benzothiazole sulfonamide HIV protease inhibitors
ATE356130T1 (en) INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES
CL2004001621A1 (en) USE OF A COMBINED THERAPY OF METOTREXATE AND OTHER ACTIVE AGENTS FOR THE TREATMENT OF Rheumatoid ARTHRITIS.
NO20040404L (en) 2- (3,5-Bis-trifluoromethyl-phenyl) -N- [6- (1,1-dioxo-1am-bda6-thiomorpholin-4-yl) -4- (2-methyl- or 4-fluoro-2- methyl substituted) phenyl-pyridin-3-yl] -N-methyl-isobutyramine.
CY1107300T1 (en) Acrylic derivatives of 5- (2- (4- (1,2-benzisothiazol-3-yl) -1-piperazinyl) ethyl) -6-chloro-1,3-dihydro-2H-indol-2-one-hour
CY1107776T1 (en) NEW Oligo-Nucleotide Derivatives for Targeted Inhibition of Gene Expression
NO20002408D0 (en) 5-HT1F antagonists
DK1161239T3 (en) 3-Cyclopropylmethoxy-4-difluoromethoxy-N- (3,5-dichloropyrid-4-yl) benzamide for the treatment of disseminated sclerosis
ATE298742T1 (en) CYCLOALKENYLSULFONAMIDE DERIVATIVES